SKYE Skye Bioscience, Inc.

Fundamentals / CIK 0001516551 / USD

Skye Bioscience, Inc. reported $5.07M in total assets and a net loss of $37.67M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open SKYE in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$6.94M$3.47M$0-$52.38MFY 2016 Net Income: -$3.18M2016FY 2017 Net Income: -$3.09M2017FY 2018 Net Income: -$19.19M2018FY 2019 Net Income: $1.05M2019FY 2020 Net Income: -$6.56M2020FY 2021 Net Income: -$8.52M2021FY 2022 Net Income: -$19.48M2022FY 2023 Net Income: -$37.64M2023FY 2024 Net Income: -$26.57M2024FY 2025 Net Income: -$55.92M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Research & Development $42.36M $18.70M $5.82M $6.01M $2.93M $1.94M $2.24M $330K $311K $939K
Total Operating Expenses $58.16M $30.19M $34.74M $18.31M $7.85M $6.29M $6.63M $4.69M $3.86M $4.47M
Operating Income -$58.16M -$30.19M -$34.74M -$18.31M -$7.85M -$6.29M -$6.63M -$4.69M -$3.86M -$4.47M
EBITDA -$57.44M -$29.89M -$34.61M -$18.20M -$7.81M -$6.29M -$6.63M -$4.69M -$3.85M -$4.46M
Interest Income $1.88M $3.03M $100K $19K $3 $29 $26 $84 -- --
Interest Expense $0 $749K $906K $665K $769K $706K $1.00M $95K $667 --
Income Before Tax -$55.92M -$26.56M -$37.64M -$19.47M -$8.52M -$6.56M $1.05M -$19.19M -$3.09M -$3.18M
Income Tax Expense $5.4K $10K $3.6K $6.7K $2.1K $1.6K $1.6K $1.6K $1.6K $1.6K
Net Income -$55.92M -$26.57M -$37.64M -$19.48M -$8.52M -$6.56M $1.05M -$19.19M -$3.09M -$3.18M
Basic EPS -$11.28 -$5.84 -$42.96 -$70.16 -$40.00 -$60.00 $20.00 -$320.00 -$220.00 -$340.00
Diluted EPS -$11.28 -$5.84 -$42.96 -$70.16 -$40.00 -$60.00 -$100.00 -$320.00 -$220.00 -$340.00
Basic Shares Outstanding 5.0M 4.6M 875.8K 277.6K 203.3K 115.4K 67.6K 60.6K 14.0K 9.5K
Diluted Shares Outstanding 5.0M 4.6M 875.8K 277.6K 203.3K 115.7K 84.8K 60.6K 14.0K 9.5K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $1.32M $3.94M $7.94M $11.47M $9.36M $14.34M $7.20M $7.79M
Total Operating Expenses -$26K $11.06M $12.67M $14.90M $13.26M $18.24M $11.76M $10.67M
Operating Income $26K -$11.06M -$12.67M -$14.90M -$13.26M -$18.24M -$11.76M -$10.67M
EBITDA $58K -$10.90M -$12.50M -$14.72M -$13.09M -$18.06M -$11.58M -$10.49M
Interest Income $49K $103K $170K $274K $418K $533K $619K $732K
Interest Expense $3.3K $3.3K $2.2K $0 $0 $0 $1.5K -$47K
Income Before Tax $69K -$10.78M -$12.51M -$14.44M -$12.75M -$17.62M -$11.10M -$9.75M
Income Tax Expense $0 $3.4K $0 $0 $0 $3.4K $2.0K $0
Net Income $69K -$10.79M -$12.51M -$14.44M -$12.75M -$17.62M -$11.10M -$9.75M
Basic EPS $0.01 -$2.16 -$2.56 -- -$2.57 -$3.52 -$2.24 --
Diluted EPS $0.01 -$2.16 -$2.56 -- -$2.57 -$3.52 -$2.24 --
Basic Shares Outstanding 5.0M 5.0M 5.0M -- 5.0M 5.0M 5.0M --
Diluted Shares Outstanding 5.0M 5.0M 5.0M -- 5.0M 5.0M 5.0M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $5.88M $68.42M $1.26M $1.24M $8.98M $2.47M $1.83M $1.85M $260K $65K
Short-Term Investments $19.85M $0 -- -- -- -- -- -- -- --
Cash & Short-Term Investments $25.74M $68.42M $1.26M $26K $8.98M $2.47M $1.83M $1.85M $260K $65K
Other Current Assets $852K $2.21M $1.12M $482K $57K $275 $7.5K $2.6K -- $7.0K
Total Current Assets $27.09M $70.83M $11.65M $8.94M $9.61M $2.66M $1.99M $1.95M $556K $279K
Property, Plant & Equipment, Net $899K $1.43M $43K $88K $88K $7.3K $2.0K $3.4K $1.4K $9.6K
Other Non-Current Assets $54K $54K $8.3K $8.3K $8.3K $0 -- -- -- $34K
Total Non-Current Assets $1.22M $1.94M $290K $167K $243K $7.3K $2.0K $3.4K $1.4K $44K
Total Assets $28.31M $72.76M $11.94M $9.11M $9.86M $2.67M $2.00M $1.96M $557K $323K
Accounts Payable $2.03M $569K $1.16M $1.67M $898K $364K $130K $16K $101K $275K
Other Current Liabilities $2.64M $654K $999K $1.37M $376K $198K $420K $184K -- --
Total Current Liabilities $8.21M $4.34M $13.90M $12.12M $3.91M $787K $971K $15.94M $806K $662K
Total Non-Current Liabilities $84K $273K $171K $0 $79K $1.43M $478K $1.58M $551K $1.11M
Total Liabilities $8.29M $4.61M $14.07M $12.12M $3.99M $2.22M $1.45M $17.52M $1.36M $1.77M
Total Debt (incl. Leases) $274K $456K $243K $79K $161K -- -- -- -- --
Common Stock $4.2K $31K $12K $3.7K $476K $288K $183K $134K $34K $22K
Retained Earnings -$186.9M -$130.9M -$104.4M -$66.74M -$47.26M -$38.73M -$32.17M -$33.23M -$14.03M -$10.94M
Total Stockholders' Equity $20.02M $68.15M -$2.13M -$3.01M $5.86M $451K $548K -$15.56M -$3.57M -$2.91M
Total Equity $20.02M $68.15M -$2.13M -$3.01M $5.86M $451K $548K -$15.56M -$3.57M -$2.91M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $4.82M $8.07M $8.15M $5.88M $18.44M $23.84M $46.42M $68.42M
Short-Term Investments $0 $2.00M $8.96M $19.85M $16.87M $24.75M $12.80M $0
Cash & Short-Term Investments $4.82M $10.06M $17.11M $25.74M $35.31M $48.59M $59.22M $68.42M
Other Current Assets $12K $480K $235K $852K $900K $733K $3.23M $2.21M
Total Current Assets $5.04M $10.96M $18.57M $27.09M $39.92M $50.58M $63.03M $70.83M
Property, Plant & Equipment, Net $20K $33K $756K $899K $1.03M $1.17M $1.30M $1.43M
Other Non-Current Assets $8.3K $8.3K $36K $54K $54K $54K $54K $54K
Total Non-Current Assets $37K $75K $850K $1.22M $1.40M $1.58M $1.77M $1.94M
Total Assets $5.07M $11.03M $19.42M $28.31M $41.32M $52.16M $64.79M $72.76M
Accounts Payable $2.45M $4.28M $3.94M $2.03M $2.83M $3.22M $1.71M $569K
Other Current Liabilities $1.08M $966K $3.35M $2.64M $2.37M $2.22M $848K $654K
Total Current Liabilities $3.71M $11.53M $10.40M $8.21M $8.37M $8.31M $5.32M $4.34M
Total Non-Current Liabilities $0 $0 $0 $84K $120K $172K $223K $273K
Total Liabilities $3.71M $11.53M $10.40M $8.29M $8.49M $8.48M $5.54M $4.61M
Total Debt (incl. Leases) $9.5K $36K $61K $274K $322K $368K $412K $456K
Common Stock $4.4K $35K $35K $4.2K $31K $31K $31K $31K
Retained Earnings -$210.1M -$210.2M -$199.4M -$186.9M -$172.4M -$159.7M -$142.1M -$130.9M
Total Stockholders' Equity $1.36M -$497K $9.01M $20.02M $32.84M $43.68M $59.25M $68.15M
Total Equity $1.36M -$497K $9.01M $20.02M $32.84M $43.68M $59.25M $68.15M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$55.92M -$26.57M -$37.64M -$19.48M -$8.52M -$6.56M $1.05M -$19.19M -$3.09M -$3.18M
Depreciation & Amortization $723K $299K $124K $115K $34K $1.9K $1.5K $1.5K $8.0K $15K
Stock-Based Compensation $7.77M $8.32M $988K $629K $869K $303K $680K $675K $609K $706K
Change in Payables $1.40M -$587K -$576K $688K $534K $235K $124K -$85K -$174K $149K
Operating Cash Flow -$43.06M -$25.24M -$13.95M -$12.74M -$6.47M -$6.05M -$6.03M -$3.94M -$3.33M -$3.55M
Capital Expenditure -$6.3K -$1.60M -$13K -$28K -$91K -$7.2K -- -$4.4K -$20K -$11K
Free Cash Flow -$43.07M -$26.84M -$13.96M -$12.77M -$6.57M -$6.06M -- -$3.95M -$3.35M -$3.56M
Investing Cash Flow -$19.50M -$246K $6.60M $5.21M -$91K -$7.2K -- -$4.4K -$20K -$11K
Common Stock Issued -- $0 $4.97M $0 $6.06M $6.09M $1.92M $3.10M -- $408K
Financing Cash Flow $30K $83.56M $16.44M -$209K $13.08M $6.70M $6.00M $5.54M $3.51M $408K
Net Change in Cash -$62.53M $58.08M $9.09M -$7.74M $6.51M $639K -$23K $1.59M $162K -$3.16M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income $69K -$10.79M -$12.51M -$14.44M -$12.75M -$17.62M -$11.10M -$9.75M
Depreciation & Amortization $31K $158K $173K $180K $179K $187K $177K $175K
Stock-Based Compensation $1.80M $1.27M $1.50M $1.62M $1.91M $2.03M $2.20M $2.09M
Change in Payables -$1.83M $341K $1.90M -$792K -$398K $1.37M $1.22M -$211K
Operating Cash Flow -$5.13M -$7.12M -$8.56M -$9.77M -$13.36M -$10.75M -$9.19M -$8.17M
Capital Expenditure $0 $0 $0 $0 $0 $0 -$6.3K -$50K
Free Cash Flow -$5.13M -$7.12M -$8.56M -$9.77M -$13.36M -$10.75M -$9.19M -$8.22M
Investing Cash Flow $2.00M $7.14M $10.90M -$2.80M $7.97M -$11.86M -$12.81M $90K
Financing Cash Flow -$117K -$101K -$72K $11K $0 $18K $0 $5.6K
Net Change in Cash -$3.25M -$81K $2.27M -$12.56M -$5.40M -$22.58M -$21.99M -$8.08M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Return on Equity (ROE) -279.3% -39.0% -- -- -145.3% -1455.4% 191.9% -- -- --
Return on Assets (ROA) -197.5% -36.5% -315.3% -213.8% -86.5% -245.6% 52.7% -980.7% -555.3% -982.8%
Current Ratio 3.30x 16.32x 0.84x 0.74x 2.46x 3.38x 2.05x 0.12x 0.69x 0.42x
Quick Ratio 3.14x 15.77x 0.09x 0.00x 2.30x 3.14x 1.88x 0.12x 0.32x 0.10x
Debt to Equity 0.01x 0.01x -- -- 0.03x -- -- -- -- --
Net Income Growth (YoY) -- -- -- -- -- -723.7% -- -- -- --
EPS Growth (YoY) -- -- -- -- -- -400.0% -- -- -- --
5Y Net Income / Share Growth -- -137.4% -- -- -- -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -2768.9% -- -636.2% -279.3% -156.0% -97.0% -55.1% -39.0%
Return on Assets (ROA) -742.6% -457.6% -295.3% -197.5% -124.0% -81.2% -50.4% -36.5%
Current Ratio 1.36x 0.95x 1.78x 3.30x 4.77x 6.09x 11.85x 16.32x
Quick Ratio 1.30x 0.87x 1.64x 3.14x 4.22x 5.85x 11.13x 15.77x
Debt to Equity 0.01x -- 0.01x 0.01x 0.01x 0.01x 0.01x 0.01x
Source: SEC EDGAR CompanyFacts (CIK 0001516551) · from April 30, 2012 Data through September 30, 2026 · synced Nov 21, 2026, 05:10 UTC · Open in terminal